𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Addition of rubidomycine to induction treatment with vincristine, prednison and L-asparaginase in standard risk childhood acute lymphocytic leukemia

✍ Scribed by A.v.d. Does-v.d. Berg; E.R.v. Wering; J.d. Koning; J.A. Rammeloo; G. Solbu; S. Suciu; G.E.v. Zanen

Book ID
113238665
Publisher
Elsevier Science
Year
1986
Tongue
English
Weight
95 KB
Volume
10
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

L-asparaginase used with cytosine arabin
L-asparaginase used with cytosine arabinoside in treatment of childhood acute lymphocytic leukemia refractory to vincristine and prednisone
✍ Smithson, William A. ;Gilchrist, Gerald S. ;Burgert, E. Omer 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 458 KB

## Abstract Eleven patients with acute lymphocytic leukemia in relapse were treated with L‐asparaginase and cytosine arabinoside (1‐β‐D‐arabinofuranosylcytosine) in induction therapy and the same drugs plus cyclophosphamide in maintenance therapy. Three patients had complete remissions lasting 6, 1

Vincristine and prednisone vs vincristin
Vincristine and prednisone vs vincristine, l-asparaginase, and prednisone for second remission induction of acute lymphocytic leukemia in children
✍ Herson, Jay ;Starling, Kenneth A. ;Dyment, Paul G. ;Humphrey, G. Bennett ;Pullen 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 332 KB

Second remission induction rates for vincristine and prednisone alone (VP) and vincristine, L-asparaginase, and prednisone (VLP) are compared for children with acute lymphocytic leukemia. No evidence of a significant difference between the second induction complete remission rate for VP (78.6%) and